Renaissance Technologies
DXTR

Renaissance Technologies’s Dextera Surgical Inc. DXTR Stock Holding History

Renaissance Technologies’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-69,572
Closed -$67K – 3556
2016
Q4 		$67K Sell
69,572
-1,100
-2% -$1.66K ﹤0.01% 3140
2016
Q3 		$133K Buy
70,672
+5,500
+8% +$11.7K ﹤0.01% 3140
2016
Q2 		$117K Buy
+65,172
New +$134K ﹤0.01% 3137

Other funds holding DXTR

Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Renaissance Technologies's DXTR Position: Q1 2017 in Review

Renaissance Technologies sold out of Dextera Surgical Inc. (DXTR) in Q1 2017, closing a stake of 69,572 shares — an estimated $67K sold.

Renaissance Technologies first reported a position in DXTR in Q2 2016 and held it in 3 quarters. The position peaked at $133K in Q3 2016. 20 funds tracked by Wall St. Rank hold DXTR as of Q1 2017.

  • Renaissance Technologies reported no remaining Dextera Surgical Inc. position as of Q1 2017 after selling out during the quarter.
  • Renaissance Technologies sold 69,572 Dextera Surgical Inc. shares in Q1 2017, an estimated $67K.
  • Renaissance Technologies first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 3 quarters.
  • Renaissance Technologies's Dextera Surgical Inc. position peaked at $133K in Q3 2016.
  • 20 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q1 2017.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.